Serum Hyaluronic Acid Levels in Cancer
Author Information
Author(s): E.H. Cooper, M.A. Forbes
Primary Institution: Unit for Cancer Research, University of Leeds
Hypothesis
The study investigates the levels of serum hyaluronic acid (HA) in patients with various types of cancer.
Conclusion
The study confirms that raised serum HA levels may accompany malignant disease, but cannot be considered a reliable tumor marker.
Supporting Evidence
- Raised serum HA levels were observed in patients with advanced cancer.
- Wilms' tumor patients showed a high incidence of greatly raised HA levels.
- Statistical significance for increased HA levels was found in pancreatic cancer, small cell lung cancer, and prostate cancer.
Takeaway
This study looked at a substance in the blood called hyaluronic acid to see if it can help tell if someone has cancer. They found that while some people with cancer have high levels, it doesn't work well as a test for everyone.
Methodology
The study used a sensitive radiometric assay to measure serum hyaluronic acid levels in cancer patients and healthy controls.
Potential Biases
The study may have bias due to the selection of controls and the variability in HA levels among different cancer types.
Limitations
The study cannot generalize the effects of metastatic involvement of a particular tissue due to individual variations in HA levels.
Participant Demographics
Participants included 121 adult patients with metastatic cancer or large local tumors and healthy controls aged 42 to 64.
Statistical Information
P-Value
P=0.0097 for pancreatic cancer, P=0.01 for small cell lung cancer, P=0.0069 for prostate cancer.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website